Doctor Tim Anthonie Christiaan de Vries

Doctor Tim Anthonie Christiaan de Vries

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Member of:

Tim A.C. de Vries is a medical doctor, currently working at the Amsterdam UMC location AMC as a PhD candidate/physician-scientist. With his research he aims to provide further insights into the use of oral anticoagulation in patients with atrial fibrillation in routine clinical practice, as well as into the role of inflammation in this common arrhythmia.

Presentations

Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe

Event: ESC Congress 2022

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly 2

Access

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Access

Outcomes of edoxaban-treated patients with atrial fibrillation and concomitant vascular disease in daily clinical practice: insights from ETNA-AF-Europe

Event: EHRA 2021

Topic: Oral Anticoagulation

Session: Prevention of stroke in atrial fibrillation

Access

Doctor Tim Anthonie Christiaan de Vries

Biography

Contributor content

Perceived frailty and clinical outcomes in men and women with atrial fibrillation treated with edoxaban: insights from the 2-year follow-up of ETNA-AF-Europe

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

Outcomes of edoxaban-treated patients with atrial fibrillation and concomitant vascular disease in daily clinical practice: insights from ETNA-AF-Europe

ESC 365 is supported by